Lilly Shares Decline Amidst Drug Performance Concerns; FDA Plans Psychedelic Vouchers

Eli Lilly's stock experienced a decline following a challenging week for its drug Foundayo, while the FDA announced plans to issue vouchers to accelerate research into psychedelic-based medicines.